Using wearable devices to monitor heart attack patients
Wearable Device for Characterizing AMI Patients After Primary PCI and Predicting the Clinical Outcomes
This study tests whether wearable devices can help monitor heart attack patients in the hospital to improve their care and predict their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | RenJi Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Trial ID | NCT06995495 on ClinicalTrials.gov |
What this trial studies
This study explores the use of wearable technology to monitor patients with acute myocardial infarction (AMI) who are receiving primary percutaneous coronary intervention (PCI). Patients will wear devices that track vital signs such as heart rate, blood pressure, and sleep patterns during their stay in the Cardiac Intensive Care Unit. The collected data will be analyzed using AI and machine learning to predict clinical outcomes and improve patient management. Follow-ups will assess cardiac function and quality of life over time.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-75 diagnosed with STEMI or NSTEMI who are undergoing PCI.
Not a fit: Patients under 18, pregnant or breastfeeding women, and those allergic to the wearable device materials may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance patient monitoring and improve clinical outcomes for heart attack patients.
How similar studies have performed: Other studies have shown promise in using wearable technology for monitoring cardiovascular patients, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18-75 years old * Diagnosed with STEMI or NSTEMI (ACC/AHA guidelines) * Half male and half female * Undergo CAG and PCI treatment; * Written informed consent. Exclusion Criteria: * People under the age of 18 years old; * Patients who are pregnant/breastfeeding; * Patients who are allergic to the metallic or plastic components of the wearable devices
Where this trial is running
Shanghai
- Renji Hospital — Shanghai, China (Recruiting)
Study contacts
- Study coordinator: Zhiguo Zou, MD, PhD
- Email: zouzhiguo@renji.com
- Phone: +86 13524596108
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.